Vanguard Group’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-1,536,333
| Closed | -$27.6M | – | 4134 |
|
|
2017
Q4 | $27.6M | Sell |
1,536,333
-95,080
| -6% | -$1.17M | ﹤0.01% | 2361 |
|
|
2017
Q3 | $19.3M | Sell |
1,631,413
-14,935
| -0.9% | -$168K | ﹤0.01% | 2504 |
|
|
2017
Q2 | $17.3M | Buy |
1,646,348
+189,561
| +13% | +$1.93M | ﹤0.01% | 2523 |
|
|
2017
Q1 | $16M | Buy |
1,456,787
+478,226
| +49% | +$5.55M | ﹤0.01% | 2538 |
|
|
2016
Q4 | $13.3M | Buy |
978,561
+9,339
| +1% | +$130K | ﹤0.01% | 2612 |
|
|
2016
Q3 | $11.9M | Sell |
969,222
-199,193
| -17% | -$2.35M | ﹤0.01% | 2603 |
|
|
2016
Q2 | $12.8M | Sell |
1,168,415
-772,197
| -40% | -$8.64M | ﹤0.01% | 2529 |
|
|
2016
Q1 | $21.2M | Sell |
1,940,612
-8,676
| -0.4% | -$110K | ﹤0.01% | 2281 |
|
|
2015
Q4 | $33.7M | Buy |
1,949,288
+281,516
| +17% | +$5.05M | ﹤0.01% | 2072 |
|
|
2015
Q3 | $33.1M | Buy |
1,667,772
+733,279
| +78% | +$16.8M | ﹤0.01% | 2059 |
|
|
2015
Q2 | $15.4M | Buy |
934,493
+236,655
| +34% | +$4.1M | ﹤0.01% | 2469 |
|
|
2015
Q1 | $10.9M | Buy |
697,838
+126,074
| +22% | +$1.95M | ﹤0.01% | 2607 |
|
|
2014
Q4 | $8.16M | Sell |
571,764
-55,237
| -9% | -$583K | ﹤0.01% | 2636 |
|
|
2014
Q3 | $4.08M | Buy |
627,001
+10,784
| +2% | +$71.6K | ﹤0.01% | 2939 |
|
|
2014
Q2 | $4.25M | Buy |
616,217
+66,123
| +12% | +$468K | ﹤0.01% | 2919 |
|
|
2014
Q1 | $3.93M | Buy |
550,094
+52,777
| +11% | +$452K | ﹤0.01% | 2947 |
|
|
2013
Q4 | $4.67M | Sell |
497,317
-47,809
| -9% | -$341K | ﹤0.01% | 2839 |
|
|
2013
Q3 | $3.4M | Sell |
545,126
-22,451
| -4% | -$140K | ﹤0.01% | 2925 |
|
|
2013
Q2 | $3.73M | Buy |
+567,577
| New | +$4.5M | ﹤0.01% | 2819 |
|
Other funds holding SCMP
Vanguard Group's SCMP Position: Q1 2018 in Review
Vanguard Group sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 1,536,333 shares — an estimated $27.6M sold.
Vanguard Group first reported a position in SCMP in Q2 2013 and held it in 19 quarters. The position peaked at $33.7M in Q4 2015. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.
- Vanguard Group reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
- Vanguard Group sold 1,536,333 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $27.6M.
- Vanguard Group first reported a position in Sucampo Pharmaceuticals, Inc. in Q2 2013 and held it in 19 quarters.
- Vanguard Group's Sucampo Pharmaceuticals, Inc. position peaked at $33.7M in Q4 2015.
- 3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.
Based on Vanguard Group's 13F filing for Q1 2018, filed 15 May 2018.